한글목차

세계 고순도 탁시폴린의 시장 규모는 2024년 2,674만 달러에 달했습니다.

이 시장은 2025-2031년 예측 기간 동안 4.06%의 CAGR로 성장하여 2031년까지 3,566만 달러에 달할 것으로 예상됩니다.

고순도 탁시포린의 세계 주요 기업으로는 Ametis JSC, Jilin Jianwei Natural Biotechnology, Kalenika Group, ROBIOS, Xi'an Sost Biotech Co.Ltd, Focusherb, Hoycome 등이 있습니다. 2024년에는 세계 5대 기업이 매출액 기준 약 91%의 점유율을 차지했습니다.

이 보고서는 고순도 탁시폴린 세계 시장을 포괄적으로 소개하며, 지역별, 국가별, 유형별, 용도별 고순도 탁시폴린 분석과 함께 총 판매량, 판매 수익, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 있습니다.

고순도 탁시폴린의 시장 규모, 추정 및 예측은 2024년을 기준 연도로, 2020년부터 2031년까지의 이력 데이터와 예측 데이터를 판매량(kg)과 판매 수익(백만 달러)으로 제공합니다. 정량적 및 정성적 분석을 통해 독자가 비즈니스/성장 전략을 수립하고, 시장 경쟁 상황을 평가하고, 현재 시장에서의 위치를 분석하고, 고순도 탁시폴린에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.

세계의 고순도 탁시폴린 시장에 대해 조사했으며, 시장 개요, 유형별·용도별·지역별 동향, 시장 진입 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 개요

• 고순도 탁시폴린 제품 소개
• 세계의 고순도 탁시폴린 시장 규모 예측
• 고순도 탁시폴린 시장 동향과 촉진요인
• 가정과 제한
• 조사 목적
• 대상 연도

제2장 기업에 의한 경쟁 분석

제3장 유형별 세분화

• 유형별 소개
• 세계의 고순도 탁시폴린 판매액, 유형별
• 세계의 고순도 탁시폴린 판매량, 유형별
• 세계의 고순도 탁시폴린 평균 가격, 유형별(2020-2031년)

제4장 용도별 세분화

• 용도별 소개
• 세계의 고순도 탁시폴린 판매액, 용도별
• 세계의 고순도 탁시폴린 판매량, 용도별
• 세계의 고순도 탁시폴린 평균 가격, 용도별(2020-2031년)

제5장 지역별 세분화

• 세계의 고순도 탁시폴린 판매액, 지역별
• 세계의 고순도 탁시폴린 판매량, 지역별
• 세계의 고순도 탁시폴린 평균 가격, 지역별(2020-2031년)
• 북미
• 유럽
• 아시아태평양
• 남미
• 중동 및 아프리카

제6장 주요 국가·지역별 세분화

• 주요 국가/지역별 고순도 탁시폴린 판매액 성장 동향, 2020년 대 2024년 대 2031년
• 미국
• 유럽
• 중국
• 일본
• 한국
• 동남아시아
• 인도

제7장 기업 개요

• Ametis JSC
• Jilin Jianwei Natural Biotechnology
• Kalenika Group
• ROBIOS
• Xi'an Sost Biotech Co.,Ltd
• Focusherb
• Hoycome
• Herbchem Biotech

제8장 산업 체인 분석

• 고순도 탁시폴린 산업 체인
• 고순도 탁시폴린 업스트림 분석
• 미드스트림 분석
• 다운스트림 분석(고객 분석)
• 판매 모델과 판매 채널

제9장 조사 결과와 결론

제10장 부록

영문목차

The global High Purity Taxifolin market size was valued at US$ 26.74 million in 2024 and is forecast to reach US$ 35.66 million by 2031 with a CAGR of 4.06% during the forecast period 2025-2031.

The global key companies of High Purity Taxifolin include Ametis JSC, Jilin Jianwei Natural Biotechnology, Kalenika Group, ROBIOS, Xi'an Sost Biotech Co.,Ltd, Focusherb, Hoycome, etc. In 2024, the global five largest players hold a share approximately 91% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for High Purity Taxifolin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of High Purity Taxifolin by region & country, by Type, and by Application.

The High Purity Taxifolin market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Purity Taxifolin.

Market Segmentation

By Company

• Ametis JSC
• Jilin Jianwei Natural Biotechnology
• Kalenika Group
• ROBIOS
• Xi'an Sost Biotech Co.,Ltd
• Focusherb
• Hoycome
• Herbchem Biotech

Segment by Type

• 92%- 98%
• Above 98%

Segment by Application

• Healthcare
• Food and Beverage
• Cosmetics
• Others

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Rest of Europe
• South America
• Brazil
• Rest of South America
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of High Purity Taxifolin manufacturer's competitive landscape, price, sales and revenue market share, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of High Purity Taxifolin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of High Purity Taxifolin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 High Purity Taxifolin Product Introduction
• 1.2 Global High Purity Taxifolin Market Size Forecast
  • 1.2.1 Global High Purity Taxifolin Sales Value (2020-2031)
  • 1.2.2 Global High Purity Taxifolin Sales Volume (2020-2031)
  • 1.2.3 Global High Purity Taxifolin Sales Price (2020-2031)
• 1.3 High Purity Taxifolin Market Trends & Drivers
  • 1.3.1 High Purity Taxifolin Industry Trends
  • 1.3.2 High Purity Taxifolin Market Drivers & Opportunity
  • 1.3.3 High Purity Taxifolin Market Challenges
  • 1.3.4 High Purity Taxifolin Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global High Purity Taxifolin Players Revenue Ranking (2024)
• 2.2 Global High Purity Taxifolin Revenue by Company (2020-2025)
• 2.3 Global High Purity Taxifolin Players Sales Volume Ranking (2024)
• 2.4 Global High Purity Taxifolin Sales Volume by Company Players (2020-2025)
• 2.5 Global High Purity Taxifolin Average Price by Company (2020-2025)
• 2.6 Key Manufacturers High Purity Taxifolin Manufacturing Base and Headquarters
• 2.7 Key Manufacturers High Purity Taxifolin Product Offered
• 2.8 Key High Purity Taxifolin Manufacturers, Established Time
• 2.9 High Purity Taxifolin Market Competitive Analysis
  • 2.9.1 High Purity Taxifolin Market Concentration Rate (2020-2025)
  • 2.9.2 Global 3 and 5 Largest Manufacturers by High Purity Taxifolin Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Purity Taxifolin as of 2024)

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 92%- 98%
  • 3.1.2 Above 98%
• 3.2 Global High Purity Taxifolin Sales Value by Type
  • 3.2.1 Global High Purity Taxifolin Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global High Purity Taxifolin Sales Value, by Type (2020-2031)
  • 3.2.3 Global High Purity Taxifolin Sales Value, by Type (%) (2020-2031)
• 3.3 Global High Purity Taxifolin Sales Volume by Type
  • 3.3.1 Global High Purity Taxifolin Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global High Purity Taxifolin Sales Volume, by Type (2020-2031)
  • 3.3.3 Global High Purity Taxifolin Sales Volume, by Type (%) (2020-2031)
• 3.4 Global High Purity Taxifolin Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Healthcare
  • 4.1.2 Food and Beverage
  • 4.1.3 Cosmetics
  • 4.1.4 Others
• 4.2 Global High Purity Taxifolin Sales Value by Application
  • 4.2.1 Global High Purity Taxifolin Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global High Purity Taxifolin Sales Value, by Application (2020-2031)
  • 4.2.3 Global High Purity Taxifolin Sales Value, by Application (%) (2020-2031)
• 4.3 Global High Purity Taxifolin Sales Volume by Application
  • 4.3.1 Global High Purity Taxifolin Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global High Purity Taxifolin Sales Volume, by Application (2020-2031)
  • 4.3.3 Global High Purity Taxifolin Sales Volume, by Application (%) (2020-2031)
• 4.4 Global High Purity Taxifolin Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global High Purity Taxifolin Sales Value by Region
  • 5.1.1 Global High Purity Taxifolin Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global High Purity Taxifolin Sales Value by Region (2020-2025)
  • 5.1.3 Global High Purity Taxifolin Sales Value by Region (2026-2031)
  • 5.1.4 Global High Purity Taxifolin Sales Value by Region (%), (2020-2031)
• 5.2 Global High Purity Taxifolin Sales Volume by Region
  • 5.2.1 Global High Purity Taxifolin Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global High Purity Taxifolin Sales Volume by Region (2020-2025)
  • 5.2.3 Global High Purity Taxifolin Sales Volume by Region (2026-2031)
  • 5.2.4 Global High Purity Taxifolin Sales Volume by Region (%), (2020-2031)
• 5.3 Global High Purity Taxifolin Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America High Purity Taxifolin Sales Value, 2020-2031
  • 5.4.2 North America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe High Purity Taxifolin Sales Value, 2020-2031
  • 5.5.2 Europe High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific High Purity Taxifolin Sales Value, 2020-2031
  • 5.6.2 Asia Pacific High Purity Taxifolin Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America High Purity Taxifolin Sales Value, 2020-2031
  • 5.7.2 South America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa High Purity Taxifolin Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions High Purity Taxifolin Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 United States
  • 6.2.1 United States High Purity Taxifolin Sales Value, 2020-2031
  • 6.2.2 United States High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.2.3 United States High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.3 Europe
  • 6.3.1 Europe High Purity Taxifolin Sales Value, 2020-2031
  • 6.3.2 Europe High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 Europe High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.4 China
  • 6.4.1 China High Purity Taxifolin Sales Value, 2020-2031
  • 6.4.2 China High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 China High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.5 Japan
  • 6.5.1 Japan High Purity Taxifolin Sales Value, 2020-2031
  • 6.5.2 Japan High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 Japan High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.6 South Korea
  • 6.6.1 South Korea High Purity Taxifolin Sales Value, 2020-2031
  • 6.6.2 South Korea High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 South Korea High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.7 Southeast Asia
  • 6.7.1 Southeast Asia High Purity Taxifolin Sales Value, 2020-2031
  • 6.7.2 Southeast Asia High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 Southeast Asia High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.8 India
  • 6.8.1 India High Purity Taxifolin Sales Value, 2020-2031
  • 6.8.2 India High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 India High Purity Taxifolin Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Ametis JSC
  • 7.1.1 Ametis JSC Company Information
  • 7.1.2 Ametis JSC Introduction and Business Overview
  • 7.1.3 Ametis JSC High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Ametis JSC High Purity Taxifolin Product Offerings
• 7.2 Jilin Jianwei Natural Biotechnology
  • 7.2.1 Jilin Jianwei Natural Biotechnology Company Information
  • 7.2.2 Jilin Jianwei Natural Biotechnology Introduction and Business Overview
  • 7.2.3 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Product Offerings
• 7.3 Kalenika Group
  • 7.3.1 Kalenika Group Company Information
  • 7.3.2 Kalenika Group Introduction and Business Overview
  • 7.3.3 Kalenika Group High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Kalenika Group High Purity Taxifolin Product Offerings
• 7.4 ROBIOS
  • 7.4.1 ROBIOS Company Information
  • 7.4.2 ROBIOS Introduction and Business Overview
  • 7.4.3 ROBIOS High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 ROBIOS High Purity Taxifolin Product Offerings
• 7.5 Xi'an Sost Biotech Co.,Ltd
  • 7.5.1 Xi'an Sost Biotech Co.,Ltd Company Information
  • 7.5.2 Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview
  • 7.5.3 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Product Offerings
• 7.6 Focusherb
  • 7.6.1 Focusherb Company Information
  • 7.6.2 Focusherb Introduction and Business Overview
  • 7.6.3 Focusherb High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Focusherb High Purity Taxifolin Product Offerings
  • 7.6.5 Focusherb Recent Development
• 7.7 Hoycome
  • 7.7.1 Hoycome Company Information
  • 7.7.2 Hoycome Introduction and Business Overview
  • 7.7.3 Hoycome High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Hoycome High Purity Taxifolin Product Offerings
• 7.8 Herbchem Biotech
  • 7.8.1 Herbchem Biotech Company Information
  • 7.8.2 Herbchem Biotech Introduction and Business Overview
  • 7.8.3 Herbchem Biotech High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Herbchem Biotech High Purity Taxifolin Product Offerings

8 Industry Chain Analysis

• 8.1 High Purity Taxifolin Industrial Chain
• 8.2 High Purity Taxifolin Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Process
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 High Purity Taxifolin Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 High Purity Taxifolin Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer